HK1203811A1 - Anticancer agent - Google Patents

Anticancer agent Download PDF

Info

Publication number
HK1203811A1
HK1203811A1 HK15103344.0A HK15103344A HK1203811A1 HK 1203811 A1 HK1203811 A1 HK 1203811A1 HK 15103344 A HK15103344 A HK 15103344A HK 1203811 A1 HK1203811 A1 HK 1203811A1
Authority
HK
Hong Kong
Prior art keywords
arctigenin
arctiin
burdock
extract
anticancer agent
Prior art date
Application number
HK15103344.0A
Other languages
English (en)
Chinese (zh)
Inventor
浩安 江角
公史 池田
千香 三好
重利 門田
重利 门田
敏樹 大窪
敏树 大洼
敏 與茂田
敏 与茂田
貴史 佈施
贵史 布施
孝則 川島
孝则 川岛
殖幹 千葉
殖干 千叶
Original Assignee
客乐谐制药株式会社
独立行政法人国立癌症研究中心
国立大学法人富山大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 客乐谐制药株式会社, 独立行政法人国立癌症研究中心, 国立大学法人富山大学 filed Critical 客乐谐制药株式会社
Publication of HK1203811A1 publication Critical patent/HK1203811A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15103344.0A 2012-03-26 2013-03-26 Anticancer agent HK1203811A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-069964 2012-03-26
JP2012069964 2012-03-26
PCT/JP2013/058692 WO2013146734A1 (ja) 2012-03-26 2013-03-26 抗癌剤

Publications (1)

Publication Number Publication Date
HK1203811A1 true HK1203811A1 (en) 2015-11-06

Family

ID=49259985

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103344.0A HK1203811A1 (en) 2012-03-26 2013-03-26 Anticancer agent

Country Status (8)

Country Link
US (1) US9700572B2 (enExample)
EP (1) EP2832355A4 (enExample)
JP (1) JP5707534B2 (enExample)
KR (1) KR20140139073A (enExample)
CN (1) CN104379143A (enExample)
HK (1) HK1203811A1 (enExample)
IN (1) IN2014MN01973A (enExample)
WO (1) WO2013146734A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5696191B2 (ja) * 2013-04-27 2015-04-08 クラシエ製薬株式会社 抗癌幹細胞剤
JP2016079163A (ja) * 2014-10-14 2016-05-16 医療環境テクノ株式会社 腫瘍を処置するための組成物およびその製造方法
JP6773665B2 (ja) * 2015-10-09 2020-10-21 クラシエ製薬株式会社 血管壁強化剤、血管壁を強化する方法および血管網形成抑制剤
JP6876502B2 (ja) * 2016-04-25 2021-05-26 クラシエホールディングス株式会社 未分化細胞除去剤
CN105832719B (zh) * 2016-04-28 2019-05-03 上海中医药大学附属龙华医院 牛蒡苷元在调节pp2a活性中的应用
CN109045010B (zh) * 2018-09-19 2021-03-30 淮海工学院 一种具有抗肿瘤作用的药物组合物及其应用
US11412028B2 (en) 2019-02-08 2022-08-09 Bluepipes, Inc. Online platform and a method for facilitating sharing of data between users
JP7526562B2 (ja) * 2019-11-21 2024-08-01 クラシエ株式会社 レンギョウ葉の加工方法および加工レンギョウ葉

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002065298A (ja) 2000-08-30 2002-03-05 Japan Science & Technology Corp 薬剤成分のスクリーニング方法
CN101036644A (zh) * 2006-03-13 2007-09-19 海南盛科天然药物研究院有限公司 含牛蒡子苷元的药用组合物及其制备方法
KR20080107794A (ko) * 2007-06-08 2008-12-11 경남대학교 산학협력단 우방자 추출물을 함유하는 항암 조성물
EP2412377B1 (en) * 2009-03-27 2018-12-26 Kracie Holdings Ltd. Burdock fruit extract containing arctigenin at high content and process for producing same
KR101538450B1 (ko) 2010-09-27 2015-07-22 구라시에제약 주식회사 악티게닌 함유 우방자 추출물 및 그 제조방법
CN102440986B (zh) * 2010-10-08 2014-12-03 鲁南制药集团股份有限公司 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途

Also Published As

Publication number Publication date
IN2014MN01973A (enExample) 2015-07-10
WO2013146734A1 (ja) 2013-10-03
US20150196576A1 (en) 2015-07-16
JPWO2013146734A1 (ja) 2015-12-14
US9700572B2 (en) 2017-07-11
JP5707534B2 (ja) 2015-04-30
EP2832355A1 (en) 2015-02-04
CN104379143A (zh) 2015-02-25
KR20140139073A (ko) 2014-12-04
EP2832355A4 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
HK1203811A1 (en) Anticancer agent
JP4963738B2 (ja) アルクチゲニン高含有ゴボウシエキス及びその製造方法
CN106109483B (zh) 具有抗肿瘤活性的二醇组/三醇组稀有人参皂苷组合物
JPWO2018212362A1 (ja) α−グルコシダーゼ活性抑制剤
KR101829637B1 (ko) 참옻나무 목심 추출물을 함유하는 항암치료 부작용에 따른 소화기능장애, 백혈구 감소증 및 골수부전증의 개선, 예방 또는 치료용 조성물
JP5696191B2 (ja) 抗癌幹細胞剤
CN105054223B (zh) 一种北青龙衣的采收方法及北青龙衣的加工方法
TWI542347B (zh) The use of arctigenin for the preparation of anticancer agents
CN106163515A (zh) 抗癌剂和副作用减轻剂
JP2014239699A (ja) 血中アディポネクチン量増加剤
CN104000877A (zh) 一种降糖组合物及其应用
CN109331093B (zh) 一种植物组合物及其应用
CN104127594A (zh) 应用于糖尿病预防与控制的植物提取组合物
KR102891427B1 (ko) 엉겅퀴 추출물을 유효성분으로 포함하는 유방암의 개선, 예방 또는 치료용 조성물
CN110279730A (zh) 一种冰川茶藨子提取物及其在制备降低餐后血糖药物中的应用
NL1013004C1 (nl) Kruidensamenstelling geschikt voor de bereiding van een farmaceutisch preparaat voor het behandelen van kanker, een extract en een farmaceutisch preparaat.
CN101505777B (zh) 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物
CN109602775B (zh) 乳苣醇提物在制备抗乳腺癌药物中的用途
KR20240052214A (ko) 자색당근 추출물을 유효성분으로 포함하는 암의 개선, 예방 또는 치료용 조성물
JP2006022002A (ja) 一酸化窒素産生抑制組成物および慢性関節炎抑制組成物
CN102824398B (zh) 紫景天在制备治疗肿瘤药物中的应用
CN116115625A (zh) 一种复方药物组合物及其用途
JP2014051535A (ja) 鉄、カルシウム、又はマグネシウムの吸収を促進する方法
CN110859830A (zh) 一种含有苯并氢化吡喃醇衍生物与茜草素型蒽醌类化合物的组合物及其剂型与用途
JP2020514257A (ja) 小腸上皮細胞でのカテキン吸収増進剤